Media Updates

PARIS, FRANCE AND MONTREAL, CANADA 22 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), Université de Montréal and IRICoR, of the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal, announced today a new research collaboration…

PARIS, FRANCE, 5 December 2025, Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that the shares of Beech Tree will be transferred to the Alasol Foundation, in accordance with the wishes of Mr. Henri Beaufour, Ipsen’s Board Member and a representative…

PARIS, FRANCE, 14 OCTOBER 2025 – Ipsen (Euronext: IPN: ADR: IPSEY) announced today that its Board of Directors has been informed of the conclusion of a new agreement1 between Highrock (controlled by Anne Beaufour), Beech Tree (controlled by Henri Beaufour)…

PARIS, FRANCE, 13 October 2025 – Ipsen announced today data to be presented at the upcoming European Society of Medical Oncology (ESMO) Symposium on 17-21 October 2025 for rare cancers and complex tumors, offering opportunities to change the course of…

Paris, France – October 8, 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of 13 scientific abstracts at The Liver Meeting® 2025, hosted by the American Association for the Study of Liver Diseases (AASLD). The abstracts span five rare…